Table 6. Effects of matrix, soy quality, and milk content in supplementary foods on SC (pmol/L) at end of the 3 months supplementation among 1,016 children with MAM1.
Main effects | Effect of LNS versus CSB by soy quality | Effects of SI versus DS by matrix | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
SI | DS | LNS | CSB | ||||||||
Matrix | |||||||||||
LNS | 162 | (3; 29) | 0.02 | 39 (20; 57) | <0.001 | −8 (−26; 11) | 0.42 | ||||
CSB | - | - | - | - | |||||||
Soy quality | |||||||||||
SI | −112 | (−24; 2) | 0.10 | 11 (−6; 30) | 0.27 | −35 (−53; −16) | <0.001 | ||||
DS | - | - | - | - | |||||||
Milk content (% of protein) | |||||||||||
50% | 9 | (−7; 25) | 0.30 | ||||||||
20% | −2 | (−18; 14) | 0.84 | ||||||||
0% | - | - |
1Data shown as mean difference (95% CI) based on intention-to-treat population. Tobit regression adjusted for baseline measure of the outcome, WLZ, LAZ, MUAC, age, sex, month of admission, and site.
2Interaction between matrix and soy quality: p < 0.001.
CSB, corn–soy blend; DS, dehulled soy; LAZ, length-for-age z-score; LNS, lipid-based nutrient supplement; MAM, moderate acute malnutrition; MUAC, mid-upper arm circumference; SC, serum cobalamin; SI, soy isolate; WLZ, weight-for-length z-score.